// App-Quantinova.ai

e23254 : EGFR and HER2 expression in ovarian cancer compared to clinical and pathological features of the patients.

Researchers

Presenter

  • Jamal Zidan

Principal Investigators

  • N/A

Medical Centers

  • Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel

Locations

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Genetic Disorder

Disease

  • Gynaecological cancer

Biomarkers

  • Epidermal growth factor receptor

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved